← Evidence map

ArticleLeukemia & lymphoma2019

Clinical effects of CD33 and MPC-1 on the prognosis of multiple myeloma treated with bortezomib.

Satoko Oka et al.PubMed ↗Publisher ↗

No numbers read from the abstract.

5 papers cite it

2019
2020
2021
2022
2023
2024
2025
2026
this papercites it
Full record →Abstract, authors, funding and every citing paper · PMID 30887866